Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evandro de Azambuja

Showing results (71-80 of 299) with videos related to

Pageof 30
Sort By:
Clinical Breast Cancer|April 2, 2020
Prognostic and Predictive Impact of Beta-2 Adrenergic Receptor Expression in HER2-Positive Breast CancerRafael Caparica, François Richard, Mariana Brandão, et al.
Oncotargets and Therapy|July 27, 2017
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinibHampig Raphael Kourie, Elie El Rassy, Florian Clatot, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2024
Response to letter re: Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysisDiogo Martins-Branco, Guilherme Nader-Marta, Chiara Molinelli, et al.
Annals of Nuclear Medicine|May 25, 2005
Pulmonary epithelial permeability in patients treated with bleomycin containing chemotherapy detected by technetium-99m diethylene triamine penta-acetic acid aerosol (99mTc-DTPA) scintigraphyEvandro de Azambuja, James Freitas Fleck, Sérgio Saldanha Menna Barreto, et al.
Journal of Geriatric Oncology|June 8, 2019
Targeted therapy for breast cancer in older patientsNoam Pondé, Hans Wildiers, Ahmad Awada, et al.
Journal of the National Cancer Institute|May 9, 2025
Response to Venkataraman and MokbelLuca Arecco, Eva Blondeaux, Elisa Agostinetto, et al.
Breast (Edinburgh, Scotland)|May 6, 2014
Cardiotoxicity of systemic agents used in breast cancerFelipe Ades, Dimitrios Zardavas, Ana Catarina Pinto, et al.
The Oncologist|April 5, 2007
Achievements in systemic therapies in the pregenomic era in metastatic breast cancerMariantonietta Colozza, Evandro de Azambuja, Nicola Personeni, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|January 11, 2005
[Non-Hodgkin's lymphoma in the thyroid: case report]Evandro de Azambuja, Sérgio Jobim de Azevedo, Roger Moreira, et al.
Cancer Treatment Reviews|November 23, 2006
The 17q12-q21 amplicon: Her2 and topoisomerase-IIalpha and their importance to the biology of solid tumoursMax S Mano, Daniela D Rosa, Evandro De Azambuja, et al.
Pageof 30

Showing results (71-80 of 299) with videos related to

Sort By:
Pageof 30
Clinical Breast Cancer|April 2, 2020
Prognostic and Predictive Impact of Beta-2 Adrenergic Receptor Expression in HER2-Positive Breast CancerRafael Caparica, François Richard, Mariana Brandão, et al.
Oncotargets and Therapy|July 27, 2017
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinibHampig Raphael Kourie, Elie El Rassy, Florian Clatot, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2024
Response to letter re: Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysisDiogo Martins-Branco, Guilherme Nader-Marta, Chiara Molinelli, et al.
Annals of Nuclear Medicine|May 25, 2005
Pulmonary epithelial permeability in patients treated with bleomycin containing chemotherapy detected by technetium-99m diethylene triamine penta-acetic acid aerosol (99mTc-DTPA) scintigraphyEvandro de Azambuja, James Freitas Fleck, Sérgio Saldanha Menna Barreto, et al.
Journal of Geriatric Oncology|June 8, 2019
Targeted therapy for breast cancer in older patientsNoam Pondé, Hans Wildiers, Ahmad Awada, et al.
Journal of the National Cancer Institute|May 9, 2025
Response to Venkataraman and MokbelLuca Arecco, Eva Blondeaux, Elisa Agostinetto, et al.
Breast (Edinburgh, Scotland)|May 6, 2014
Cardiotoxicity of systemic agents used in breast cancerFelipe Ades, Dimitrios Zardavas, Ana Catarina Pinto, et al.
The Oncologist|April 5, 2007
Achievements in systemic therapies in the pregenomic era in metastatic breast cancerMariantonietta Colozza, Evandro de Azambuja, Nicola Personeni, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|January 11, 2005
[Non-Hodgkin's lymphoma in the thyroid: case report]Evandro de Azambuja, Sérgio Jobim de Azevedo, Roger Moreira, et al.
Cancer Treatment Reviews|November 23, 2006
The 17q12-q21 amplicon: Her2 and topoisomerase-IIalpha and their importance to the biology of solid tumoursMax S Mano, Daniela D Rosa, Evandro De Azambuja, et al.
Pageof 30